In Re Brian W. Baird, Art F. Diaz, William H. Dickstein and Charles M. Seymour

16 F.3d 380, 29 U.S.P.Q. 2d (BNA) 1550, 1994 U.S. App. LEXIS 1114
CourtCourt of Appeals for the Federal Circuit
DecidedJanuary 19, 1994
Docket93-1262
StatusPublished
Cited by29 cases

This text of 16 F.3d 380 (In Re Brian W. Baird, Art F. Diaz, William H. Dickstein and Charles M. Seymour) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Brian W. Baird, Art F. Diaz, William H. Dickstein and Charles M. Seymour, 16 F.3d 380, 29 U.S.P.Q. 2d (BNA) 1550, 1994 U.S. App. LEXIS 1114 (Fed. Cir. 1994).

Opinion

*381 LOURIE, Circuit Judge.

Applicants Brian W. Baird, Art F. Diaz, William H. Dickstein, and Charles M. Seymour (collectively Baird) 1 appeal from the October 15, 1992 decision of the U.S. Patent and Trademark Office (PTO) Board of Patent Appeals and Interferences, Appeal No. 92-0860, affirming the examiner’s final rejection of claims 1-5 of application Serial No. 07/333,524, entitled “Flash Fusible Toner Resins,” as unpatentable on the ground of obviousness under 35 U.S.C. § 103 (1988). We reverse.

BACKGROUND

Baird’s application is directed to a flash fusible toner comprising a polyester of bis-phenol A and an aliphatic dicarboxylic acid. Synthesis of the toner compositions involves the acetylation of bisphenol A and the reaction of that product with an aliphatic dicar-boxylie acid selected from the group consisting of succinic acid, glutarie acid, and adipic acid. The application discloses that toners containing bisphenol A have optimal characteristics for flash fusing including, inter alia, high thermal stability and low critical surface energy.

Claim 1, the only claim at issue, reads as follows:

1. A flash fusible toner comprising a binder resin which is a bisphenol A polyester containing an aliphatic di[carboxylie] acid selected from the group consisting of succinic acid, glutarie acid and adipic acid.

Claim 1 stands rejected as obvious over U.S. Patent 4,634,649 to Knapp et al., which relates to developer compositions comprised of, inter alia, the polymeric esterification product of a dicarboxylic acid and a diphenol of the following generic formula:

[[Image here]]

wherein R is selected from substituted and unsubstituted alkylene radicals having from about 2 to about 12 carbon atoms, alkylidene radicals having from 1 to 12 carbon atoms and cycloalkylidene radicals having from 3 to 12 carbons atoms; R' and R" are selected from substituted and unsubstituted alkylene radicals having from 2 to 12 carbon atoms, alkylene arylene radicals having from 8 to 12 carbon atoms and arylene radicals; X and X' are selected from hydrogen or an alkyl radical having from 1 to 4 carbon atoms; and each n is a number from 0 (zero) to 4.

Col. 4, lines 16-38. The Knapp formula contains a broad range of variables and thus encompasses a large number of different diphenols, one of which is bisphenol A, which is shown in Baird’s application as having the following structure:

Knapp also discloses that the dicarboxylic acids have the general formula:

HOOCR" 'ngCOOH

*382 wherein R"' is a substituted or unsubstituted alkylene radical having from 1 to 12 carbon atoms, arylene radicals or alkylene arylene radicals having from 10 to 12 carbon atoms and 1)3 is a number of less than 2.

Col. 5, lines 6-14. Twenty typical dicarbox-ylic acids are recited, including succinic acid, glutaric acid, and adipic acid, the dicarboxylic acids recited in claim 1.

The examiner rejected claim 1 as obvious on the ground that Knapp specifically discloses as components of his esters the three dicarboxylic acids recited in claim 1 and a generic formula which encompasses bisphe-nol A. Recognizing that bisphenol A is defined when certain specific variables are chosen, the examiner reasoned that bisphenol A “may be easily derived from the generic formula of the diphenol in [Knapp] and all the motivation the worker of ordinary skill in the art needs to arrive at the particular polyester of the instant claim[ ] is to follow [that formula].”

The Board upheld the examiner’s rejection. It rejected Baird’s argument that there was no motivation for one to select bisphenol A from Knapp and summarily concluded that “the fact that [the claimed] binder resin is clearly encompassed by the generic disclosure of Knapp ... provides ample motivation for the selection of [the claimed composition].” Slip op. at 3. The Board’s decision was affirmed on reconsideration.

DISCUSSION

The only issue before us is whether the record supports the Board’s conclusion that, in view of the teachings of Knapp, the claimed compounds 2 would have been obvious to one of ordinary skill in the art. We review an obviousness determination by the Board de novo, while we review underlying factual findings for clear error. In re Beattie, 974 F.2d 1309, 1311, 24 USPQ2d 1040, 1041 (Fed.Cir.1992).

Baird does not dispute the fact that the generic diphenol formula of Knapp encompasses bisphenol A Nor does Baird dispute that Knapp specifically discloses the three dicarboxylic acids recited in claim 1. Rather, Baird argues that there is no suggestion in Knapp to select bisphenol A from the vast number of diphenols covered by the generic formula and that the Board thus erred in concluding that the claimed compounds would have been obvious.

What a reference teaches is a question of fact. Beattie, 974 F.2d at 1311, 24 USPQ2d at 1041. The fact that a claimed compound may be encompassed by a disclosed generic formula does not by itself render that compound obvious. In re Jones, 958 F.2d 347, 350, 21 USPQ2d 1941, 1943 (Fed.Cir.1992) (rejecting Commissioner’s argument that “regardless [] how broad, a disclosure of a chemical genus renders obvious any species that happens to fall within it”). Jones involved an obviousness rejection of a claim to a specific compound, the 2-(2'-aminoethoxy)ethanol salt of 2-methoxy-3,6-dichlorobenzoic acid (dicamba), as obvious in view of, inter alia, a prior art reference disclosing a genus which admittedly encompassed the claimed salt. We reversed the Board’s rejection, reasoning that the prior art reference encompassed a “potentially infinite genus” of salts of dieamba and listed several such salts, but that it did not disclose or suggest the claimed salt. Id.

In the instant ease, the generic diphenol formula disclosed in Knapp contains a large number of variables, and we estimate that it encompasses more than 100 million different diphenols, only one of which is bisphenol A. While the Knapp formula unquestionably encompasses bisphenol A when specific variables are chosen, there is nothing in the disclosure of Knapp suggesting that one should select such variables. Indeed, Knapp appears to teach away from the selection of bisphenol A by focusing on more complex diphenols, including 2,2-bis(4-beta-hydroxye-thoxyphenyl)propane, 2,2-bis(4-hydroxypro-poxyphenyl)propane, and 2,2-bis(4-hydroxyis-opropoxyphenyl)propane. Col. 4, lines 51-64. Knapp teaches that in preferred diphenols, R *383

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Twitter, Inc. v. Vidstream LLC
Federal Circuit, 2020
Bradium Techs. LLC v. Andrei IANCU
923 F.3d 1032 (Federal Circuit, 2019)
In Re: Rhoads
646 F. App'x 967 (Federal Circuit, 2016)
In Re Rosuvastatin Calcium Patent Litigation
719 F. Supp. 2d 388 (D. Delaware, 2010)
Senju Pharmaceutical Co. Ltd. v. Apotex Inc.
717 F. Supp. 2d 404 (D. Delaware, 2010)
Atofina v. Great Lakes Chemical Corporation
441 F.3d 991 (Federal Circuit, 2006)
Eli Lilly & Co. v. Zenith Goldline Pharmaceuticals, Inc.
364 F. Supp. 2d 820 (S.D. Indiana, 2005)
Genzyme Corp. v. ATRIUM MEDICAL CORP.
315 F. Supp. 2d 552 (D. Delaware, 2004)
Pharmacia & Upjohn Co. v. Ranbaxy Pharmaceuticals, Inc.
85 F. App'x 205 (Federal Circuit, 2003)
In Re Lance G. Peterson and Ioannis Vasatis
315 F.3d 1325 (Federal Circuit, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
16 F.3d 380, 29 U.S.P.Q. 2d (BNA) 1550, 1994 U.S. App. LEXIS 1114, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-brian-w-baird-art-f-diaz-william-h-dickstein-and-charles-m-cafc-1994.